InnovAge Holding Corp. Increase (Decrease) in Deferred Revenue
InnovAge Holding Corp. (INNV) reported Increase (Decrease) in Deferred Revenue of $275.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-05-08
- InnovAge Holding Corp. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was $0.00.
- InnovAge Holding Corp. increase (decrease) in deferred revenue for the quarter ending 2025-03-31 was $0.00.
- InnovAge Holding Corp. increase (decrease) in deferred revenue for the quarter ending 2024-12-31 was $0.00.
- InnovAge Holding Corp. increase (decrease) in deferred revenue for the quarter ending 2024-09-30 was $0.00.
- InnovAge Holding Corp. increase (decrease) in deferred revenue for fiscal 2025 was $0.00.
- InnovAge Holding Corp. increase (decrease) in deferred revenue for fiscal 2024 was -$28.11M, a 200.00% decline from fiscal 2023.
- InnovAge Holding Corp. increase (decrease) in deferred revenue for fiscal 2023 was $28.11M.
- InnovAge Holding Corp. increase (decrease) in deferred revenue for fiscal 2020 was $2.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-03-31 | $275.00K 10-Q · filed 2026-05-08 | |||
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $0.00 10-K · filed 2025-09-09 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $0.00 10-Q · filed 2025-02-04 | $0.00 derived: sum of 3 quarters · filed 2025-09-09 | $0.00 derived: sum of 4 quarters · filed 2025-09-09 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-09-09 | $0.00 derived: sum of 3 quarters · filed 2025-09-09 | -$26.09M derived: sum of 4 quarters · filed 2025-09-09 |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $0.00 derived: sum of 2 quarters · filed 2025-09-09 | -$26.09M derived: sum of 3 quarters · filed 2025-09-09 | -$28.11M 10-K · filed 2025-09-09 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | -$26.09M derived: sum of 2 quarters · filed 2025-05-06 | -$28.11M 10-Q · filed 2025-05-06 | $0.00 derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$26.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | -$28.11M 10-Q · filed 2025-02-04 | $0.00 derived: sum of 3 quarters · filed 2025-02-04 | $0.00 derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$2.02M 10-Q · filed 2024-11-05 | $26.09M derived: sum of 2 quarters · filed 2024-11-05 | $26.09M derived: sum of 3 quarters · filed 2024-11-05 | $2.73M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $28.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $28.11M derived: sum of 2 quarters · filed 2024-09-10 | $4.75M derived: sum of 3 quarters · filed 2024-09-10 | $28.11M 10-K · filed 2024-09-10 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | -$23.36M derived: sum of 2 quarters · filed 2024-05-07 | $0.00 10-Q · filed 2024-05-07 | |
| 2022-12-31 | -$23.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $0.00 10-Q · filed 2024-02-06 | ||
| 2022-09-30 | $23.36M 10-Q · filed 2023-11-07 | |||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $2.00K 10-K · filed 2021-09-23 | ||
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |